Engrail Therapeutics
Engrail Therapeutics is a clinical-stage pharmaceutical company that develops precision-targeted therapeutics.
$157M Series B+ ·
Led by F-Prime Capital · Source: fundraisingfox.com
Total raised: $221M across 3 sourced rounds
All 3 rounds ↓Signals
About Engrail Therapeutics
It aims to deliver transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental disorders. The company advances assets through development to commercialization.
Engrail Therapeutics | 2342 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $157M | fundraisingfox.com | ||
| Series A | $32M | finsmes.com | ||
| Series A | $32M | finsmes.com |
Timeline
- X account created
- Website created
Founders and team
SC
Stephen Cunningham FounderVS
Vikram Sudarsan FounderKE
Kimberly E. Vanover Chief Scientific OfficerPC
Paul Cayer CFO
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | Date not given |
Investors
AAberdeen
EEight Roads Ventures
FF-Prime Capitallead investor
FForbion Capital Partnerslead investor
FForesite Capital
LLongwood Fund
NNan Fung Life Scienceslead investor
NNorwest Venture Partnerslead investor
PPivotal Life Sciences
RRed Tree Venture Capital
RRiverVest
YYsios Capital
Companies like Engrail Therapeutics
DDraig Therapeutics$65M Series B+ · Jul 2026
NNoema PharmaSeries B+ · Nov 2025
VVaderis Therapeutics$152M Series B+ · Aug 2026
NNeurosterix$105M Series B+ · Nov 2026
CComplement TherapeuticsSeries A · Apr 2023
EElevara$70M Series A · Oct 2025
Other companies backed by F-Prime Capital
TT-Therapeutics$133M Series B+ · Nov 2026
EEka Robotics$150M Series A · Oct 2026
AAblePay Health$20M Series A · Oct 2026
AArboretum$30M Series A · Oct 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
AAmber Therapeutics$100M Series A · Jul 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/engrail-therapeutics (get a free API key).